Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide
- 30 September 2003
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 91 (3), 309-313
- https://doi.org/10.1016/s1081-1206(10)63536-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Predictive Value of Exhaled Nitric Oxide Measurements in Assessing Changes in Asthma ControlAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover studyThe Journal of Pediatrics, 2001
- Evaluation of Salmeterol or Montelukast as Second-Line Therapy for Asthma Not Controlled With Inhaled CorticosteroidsChest, 2001
- Effects of adding a leukotriene antagonist or a long-acting beta2-agonist in asthmatic patients with the glycine-16 beta2-adrenoceptor genotypeThe American Journal of Medicine, 2000
- Long-acting ?2-agonists in management of childhood asthma: A critical review of the literaturePediatric Pulmonology, 2000
- Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: A preliminary studyPediatric Pulmonology, 1999
- An Antiinflammatory Effect of Salmeterol, a Long-acting β2 Agonist, Assessed in Airway Biopsies and Bronchoalveolar Lavage in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist MontelukastAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task ForceEuropean Respiratory Journal, 1997
- Standardization of Spirometry, 1994 Update. American Thoracic Society.American Journal of Respiratory and Critical Care Medicine, 1995